Other News To Note
Friday, August 31, 2012
Pluristem Therapeutics Inc., of Haifa, Israel, said that it is requesting orphan drug status from the FDA for PLacental eXpanded (PLX) cells to treat aplastic anemia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.